Bioxytran secures attested Free Sale Certificate for A-SUQAR, targeting UAE and Gulf markets

BIOXYTRAN, INC

A-SUQAR received a government-issued Free Sale Certificate, legalized by the issuing country's Ministry of Foreign Affairs and prepared for attestation for UAE use.
Certificate confirms A-SUQAR is lawfully manufactured and freely sold as a food and health supplement; Bioxytran plans UAE product registration with its distribution partner.
Bioxytran will evaluate registration pathways in Saudi Arabia, Kuwait and other GCC markets; launch timing depends on completion of local regulatory requirements.
A-SUQAR is a pre-meal chewable tablet using polysaccharides to slow intestinal carbohydrate enzymes; it is regulated as a U.S. dietary supplement, not an FDA-approved drug.
Release cites about 7.5M adults with diabetes across UAE, Saudi Arabia and Kuwait; UAE prevalence 20.7%, Saudi 23.1%, Kuwait 25.6% (IDF 2025).

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.